MediFind
Condition

Acromegaloid Facial Appearance Syndrome

Condition 101

What are the alternative names for Acromegaloid Facial Appearance Syndrome?

  • AFA syndrome
  • Thick lips and oral mucosa

Top Global Doctors

Annamaria A. Colao
Elite
Annamaria A. Colao
Naples, 72, IT
MG
Elite
Monica R. Gadelha
Ilha, RJ, BR
RH
Elite
Rudolf Happle
Freiburg, BW, DE
PC
Elite
Philippe Chanson
Paris, 11, FR
AG
Elite
Andrea Giustina
Milan, 25, IT

Latest Research

Latest Advance
Study
  • Condition: Acromegaly
  • Journal: BMC endocrine disorders
  • Treatment Used: Somatostatin Analogues (SAs) with Pegvisomant
  • Number of Patients: 0
  • Published —
This study evaluated the effectiveness of combined therapy with somatostatin analogues (drugs that block the extra release of hormones) with pegvisomant for the treatment of acromegaly (when the pituitary gland produces too much growth hormone during adulthood).
Latest Advance
Study
  • Condition: Metastatic Colon Adenocarcinoma
  • Journal: Journal of cancer research and therapeutics
  • Treatment Used: Oxaliplatin, Fluorouracil, and Folinic Acid Combined with Cetuximab
  • Number of Patients: 1
  • Published —
This case report discusses a patient with metastatic colon adenocarcinoma (tumor in the glands of the large intestine that has spread to other organs) who was treated with oxaliplatin, fluorouracil, and folinic acid combined with cetuximab.
Latest Advance
Study
  • Condition: Non-Scarring Alopecia
  • Journal: International journal of dermatology
  • Treatment Used: Low-Dose Oral Inoxidil
  • Number of Patients: 10218
  • Published —
The study researched the use of low-dose oral inoxidil for patients with non-scarring alopecia.
Latest Advance
Study
  • Condition: Acromegaly
  • Journal: European journal of endocrinology
  • Treatment Used: Fractionated Radiotherapy or Radiosurgery
  • Number of Patients: 352
  • Published —
This study compared the clinical outcome of using fractionated radiotherapy or stereotactic radiosurgery to treat patients with acromegaly.

Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 10
  • Start Date: September 1, 2020
A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 500
  • Start Date: April 15, 2020
Post-marketing Surveillance Study to Evaluate the Clinical Utility of ACRODAT in an International, Randomised, Non-interventional Study